Sam Fazeli
speaker
906 appearances
5 recordings
1 series
first heard Oct 2025
last heard 31 Mar
Sam Fazeli’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 5 in all, peaking in Mar 2026 with 2.
Appearances
Vanguards of Healthcare by Bloomberg Intelligence · Fosun Pharma’s Drive Beyond China · 17 Nov 2025
podcast
How does that all come together?
Great.
Now I'm going to move on to China quickly.
I wish we had more time.
There's so many interesting... So another drug that I was quite keen on, it was PD-1 targeted IL-2 fusion protein.
And it's funny, I just saw a paper published yesterday, or two days ago, October 13th,
From Kevin Barry's lab, IL-2 signaling induces NK cell production of FLT3LG, augmenting anti-PD-1 immunotherapy.
There's a lot of interest in these smart cytokines, etc.
But we don't have much time for that.
Maybe that's a reason for you to accept another invitation from me in the future.
We'll think about it.
But I want to talk about China Biotech.
going by the HS Bio Index, is up 70% in the past 12 months versus 5% for the US XBI, which is the S&P 500 Biotech ETF Index.
What's been, do you think, behind this?
I do remember about this time last year I was in China.
We had an event in our Hong Kong office and there wasn't as much positivity.
I mean, it was there, but not as much.
And people were
nagging about two or three months, years of VCs have pulled back a little bit, etc.
So it sounded the same as I'm hearing in US, Europe.
Showing 661–680 of 906 · page 34 of 46
← Previous
Next →